South Korea Metagenomics Market Size & Outlook, 2024-2030
- Biotechnology
- Genomics & Genetic Engineering
- Metagenomics Market Outlook
- Genomics & Genetic Engineering
Global Market
Related Markets
Ask Prism AI about the metagenomics market
Get cited answers from GVR research on market growth, segments, regulations and forecasts.
- Source-linked answers
- Market-specific context
- Traceable figures
South Korea metagenomics market highlights
- The South Korea metagenomics market generated a revenue of USD 27.0 million in 2023 and is expected to reach USD 65.2 million by 2030.
- The South Korea market is expected to grow at a CAGR of 13.4% from 2024 to 2030.
- In terms of segment, kits & reagents was the largest revenue generating product in 2023.
- Sequencing & Data Analytics Services is the most lucrative product segment registering the fastest growth during the forecast period.
Metagenomics market data book summary
| Market revenue in 2023 | USD 27.0 million |
| Market revenue in 2030 | USD 65.2 million |
| Growth rate | 13.4% (CAGR from 2023 to 2030) |
| Largest segment | Kits & reagents |
| Fastest growing segment | Sequencing & Data Analytics Services |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Kits & Reagents, Sequencing & Data Analytics Services, Software |
| Key market players worldwide | Bio-Rad Laboratories Inc, Illumina Inc, PerkinElmer, Thermo Fisher Scientific Inc, Novogene, Promega, Qiagen NV, Takara Bio Inc, Oxford Nanopore Technologies PLC, Roche Holding AG |
Other key industry trends
- In terms of revenue, South Korea accounted for 1.3% of the global metagenomics market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Asia Pacific, China metagenomics market is projected to lead the regional market in terms of revenue in 2030.
- China is the fastest growing regional market in Asia Pacific and is projected to reach USD 244.2 million by 2030.
South Korea exhibits strong potential for R&D capabilities in pharmaceutical and biopharmaceutical sectors, which is expected to boost the demand for NGS products in research. Cancer research has become a national priority for the Korean government. It supports several universities, institutions, and researchers to facilitate cancer research activities, which is anticipated to create major demand for NGS products in the coming years.
Furthermore, increasing R&D investments by key pharmaceutical companies in South Korea are anticipated to create a lucrative environment for market growth. For instance, in June 2019, AstraZeneca announced its plans to spend USD 630.0 million on R&D in South Korea over the next 5 years.
Similarly, in June 2022, Theragen Bio was selected for a state project to develop advanced chips for genomic analysis, which would be useful in identifying the genetic cause of chronic diseases in the Korean population.
No credit card required*
Customize the Report
20% free customization
- Include
- Countries, segments, points
- Tailor
- To your product definition
- Extend
- Deeper competitor detail
- Or
- A fully bespoke study
- Turnaround
- 5–10 working days
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Metagenomics Market Scope
Metagenomics Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Thermo Fisher Scientific Inc | View profile | 122,000 | 168 Third Avenue, Waltham, MA, United States, 02451 | www.thermofisher.com |
| Roche Holding AG | View profile | 103,605 | Grenzacherstrasse 124, Basel, Switzerland, 4070 | www.roche.com |
| Illumina Inc | View profile | 9,300 | 5200 Illumina Way, San Diego, CA, United States, 92122 | www.illumina.com |
| Bio-Rad Laboratories Inc | View profile | 8,030 | 1000 Alfred Nobel Drive, Hercules, CA, United States, 94547 | www.bio-rad.com |
| Qiagen NV | View profile | 5,900 | Hulsterweg 82, Venlo, LI, Netherlands, 5912 PL | www.qiagen.com |
| Takara Bio Inc | View profile | 1,793 | Nojihigashi 7-4-38 Kusatu, Shiga, Otsu, Japan, 520-0058 | www.takara-bio.co.jp |
| PerkinElmer | View profile | 10001+ | Waltham, Massachusetts, United States, North America | www.perkinelmer.com |
| Novogene | View profile | 501-1000 | Beijing, Beijing, China, Asia | en.novogene.com/ |
| Promega | View profile | 5001-10000 | Madison, Wisconsin, United States, North America | www.promega.com/es |
| Oxford Nanopore Technologies PLC | View profile | 1,133 | Edmund Halley Road, Gosling Building, Oxford Science Park, Oxford, Oxfordshire, United Kingdom, OX4 4DQ | www.nanoporetech.com |
South Korea Metagenomics Market Outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to Metagenomics Market Outlook will help companies and investors design strategic landscapes.
Kits & Reagents was the largest segment with a revenue share of 61.48% in 2023.
Horizon Databook has segmented the South Korea metagenomics market based on kits & reagents, sequencing & data analytics services, software covering the revenue growth of each sub-segment from 2018 to 2030.
South Korea exhibits strong potential for R&D capabilities in pharmaceutical and biopharmaceutical sectors, which is expected to boost the demand for NGS products in research. Cancer research has become a national priority for the Korean government. It supports several universities, institutions, and researchers to facilitate cancer research activities, which is anticipated to create major demand for NGS products in the coming years.
Furthermore, increasing R&D investments by key pharmaceutical companies in South Korea are anticipated to create a lucrative environment for market growth. For instance, in June 2019, AstraZeneca announced its plans to spend USD 630.0 million on R&D in South Korea over the next 5 years.
Similarly, in June 2022, Theragen Bio was selected for a state project to develop advanced chips for genomic analysis, which would be useful in identifying the genetic cause of chronic diseases in the Korean population.
- South Korea Metagenomics Market Application Outlook (Revenue, USD Million , 2018-2030)
- Others
- Clinical Diagnostics
- Drug Discovery
- Biotechnology
- Environmental
- Food & nutrition
- South Korea Metagenomics Market Technology Outlook (Revenue, USD Million , 2018-2030)
- Whole Genome Sequencing
- Shotgun Sequencing
- Others
- 16S Sequencing
- South Korea Metagenomics Market Product Outlook (Revenue, USD Million , 2018-2030)
- Sequencing & Data Analytics Services
- Kits & Reagents
- Software
- South Korea Metagenomics Market Workflow Outlook (Revenue, USD Million , 2018-2030)
- Pre-sequencing
- Sequencing
- Data Analysis
Reasons to subscribe to Metagenomics Market Outlook databook
- Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
- Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
- Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
- Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
- Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Metagenomics Market Outlook databook
- Our clientele includes a mix of Metagenomics Market Outlook companies, investment firms, advisory firms & academic institutions.
- 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
- Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
- The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the South Korea Metagenomics Market Outlook, including forecasts for subscribers. This country databook contains high-level insights into South Korea Metagenomics Market Outlook from 2018 to 2030, including revenue numbers, major trends, and company profiles.
South Korea Metagenomics Market, 2018-2030 (US$M)
South Korea metagenomics market statistics, by application, 2018-2030 (US$M)
